accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001193125-26-331138 | 1521036 | Lantheus Holdings, Inc. | LNTH | 2026-08-04 | 8-K | ind | false | d167446dex21.htm | https://www.sec.gov/Archives/edgar/data/1521036/000119312526331138/d167446dex21.htm |
0001326110-26-000077 | 1326110 | ImmunityBio, Inc. | IBRX | 2026-08-04 | 8-K | pdufa | false | ibrx-202684x8kexhibit991.htm | https://www.sec.gov/Archives/edgar/data/1326110/000132611026000077/ibrx-202684x8kexhibit991.htm |
0001193125-26-331381 | 1676725 | IDEAYA Biosciences, Inc. | IDYA | 2026-08-04 | 8-K | topline | false | idya-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1676725/000119312526331381/idya-ex99_1.htm |
0001193125-26-331381 | 1676725 | IDEAYA Biosciences, Inc. | IDYA | 2026-08-04 | 8-K | endpoint_met | false | idya-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1676725/000119312526331381/idya-ex99_1.htm |
0001193125-26-331381 | 1676725 | IDEAYA Biosciences, Inc. | IDYA | 2026-08-04 | 8-K | interim | false | idya-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1676725/000119312526331381/idya-ex99_1.htm |
0001104659-26-090086 | 1802665 | Harmony Biosciences Holdings, Inc. | HRMY | 2026-08-04 | 8-K | topline | false | hrmy-20260804xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1802665/000110465926090086/hrmy-20260804xex99d1.htm |
0001104659-26-090086 | 1802665 | Harmony Biosciences Holdings, Inc. | HRMY | 2026-08-04 | 8-K | pdufa | false | hrmy-20260804xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1802665/000110465926090086/hrmy-20260804xex99d1.htm |
0000882095-26-000028 | 882095 | GILEAD SCIENCES, INC. | GILD | 2026-08-04 | 8-K | interim | false | exhibit991earningspressrel.htm | https://www.sec.gov/Archives/edgar/data/882095/000088209526000028/exhibit991earningspressrel.htm |
0001140361-26-031058 | 1133416 | GALECTIN THERAPEUTICS INC | GALT | 2026-08-04 | 8-K | fast_track | false | ef20079045_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1133416/000114036126031058/ef20079045_ex99-1.htm |
0001193125-26-331563 | 1829802 | Faeth Therapeutics, Inc. | FTH | 2026-08-04 | 8-K | topline | false | d168633dex991.htm | https://www.sec.gov/Archives/edgar/data/1829802/000119312526331563/d168633dex991.htm |
0001690585-26-000033 | 1690585 | Dianthus Therapeutics, Inc. /DE/ | DNTH | 2026-08-04 | 8-K | topline | false | dnth-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1690585/000169058526000033/dnth-ex99_1.htm |
0001690585-26-000033 | 1690585 | Dianthus Therapeutics, Inc. /DE/ | DNTH | 2026-08-04 | 8-K | interim | false | dnth-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1690585/000169058526000033/dnth-ex99_1.htm |
0001690585-26-000033 | 1690585 | Dianthus Therapeutics, Inc. /DE/ | DNTH | 2026-08-04 | 8-K | orphan | false | dnth-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1690585/000169058526000033/dnth-ex99_1.htm |
0000879407-26-000058 | 879407 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | 2026-08-04 | 8-K | topline | false | arwr-202608048kex991.htm | https://www.sec.gov/Archives/edgar/data/879407/000087940726000058/arwr-202608048kex991.htm |
0000879407-26-000058 | 879407 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | 2026-08-04 | 8-K | endpoint_met | false | arwr-202608048kex991.htm | https://www.sec.gov/Archives/edgar/data/879407/000087940726000058/arwr-202608048kex991.htm |
0000879407-26-000058 | 879407 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | 2026-08-04 | 8-K | breakthrough | false | arwr-202608048kex991.htm | https://www.sec.gov/Archives/edgar/data/879407/000087940726000058/arwr-202608048kex991.htm |
0000879407-26-000058 | 879407 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | 2026-08-04 | 8-K | fast_track | false | arwr-202608048kex991.htm | https://www.sec.gov/Archives/edgar/data/879407/000087940726000058/arwr-202608048kex991.htm |
0000879407-26-000058 | 879407 | ARROWHEAD PHARMACEUTICALS, INC. | ARWR | 2026-08-04 | 8-K | orphan | false | arwr-202608048kex991.htm | https://www.sec.gov/Archives/edgar/data/879407/000087940726000058/arwr-202608048kex991.htm |
0000318154-26-000124 | 318154 | AMGEN INC | AMGN | 2026-08-04 | 8-K | clinical_hold | true | amgn-20260630earningsrelea.htm | https://www.sec.gov/Archives/edgar/data/318154/000031815426000124/amgn-20260630earningsrelea.htm |
0001193125-26-332858 | 1070494 | ACADIA PHARMACEUTICALS INC | ACAD | 2026-08-04 | 8-K | topline | false | acad-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1070494/000119312526332858/acad-ex99_1.htm |
0001193125-26-332858 | 1070494 | ACADIA PHARMACEUTICALS INC | ACAD | 2026-08-04 | 8-K | fast_track | false | acad-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1070494/000119312526332858/acad-ex99_1.htm |
0001213900-26-085235 | 1946563 | 60 DEGREES PHARMACEUTICALS, INC. | null | 2026-08-04 | 8-K | clinical_hold | true | ea030026001ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1946563/000121390026085235/ea030026001ex10-1.htm |
0000875320-26-000256 | 875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | 2026-08-03 | 8-K | interim | false | ex-991_q22026.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532026000256/ex-991_q22026.htm |
0000875320-26-000256 | 875320 | VERTEX PHARMACEUTICALS INC / MA | VRTX | 2026-08-03 | 8-K | pdufa | false | ex-991_q22026.htm | https://www.sec.gov/Archives/edgar/data/875320/000087532026000256/ex-991_q22026.htm |
0001437749-26-025304 | 1001316 | TG THERAPEUTICS, INC. | TGTX | 2026-08-03 | 8-K | topline | false | ex_997107.htm | https://www.sec.gov/Archives/edgar/data/1001316/000143774926025304/ex_997107.htm |
0001437749-26-025304 | 1001316 | TG THERAPEUTICS, INC. | TGTX | 2026-08-03 | 8-K | endpoint_met | false | ex_997107.htm | https://www.sec.gov/Archives/edgar/data/1001316/000143774926025304/ex_997107.htm |
0001193125-26-330537 | 1623526 | Stoke Therapeutics, Inc. | STOK | 2026-08-03 | 8-K | breakthrough | false | stok-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1623526/000119312526330537/stok-ex99_1.htm |
0001193125-26-330537 | 1623526 | Stoke Therapeutics, Inc. | STOK | 2026-08-03 | 8-K | orphan | false | stok-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1623526/000119312526330537/stok-ex99_1.htm |
0001193125-26-329528 | 2042347 | Seaport Therapeutics, Inc. | SPTX | 2026-08-03 | 8-K | topline | false | sptx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2042347/000119312526329528/sptx-ex99_1.htm |
0001104659-26-089425 | 1356576 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 2026-08-03 | 8-K | clinical_hold | true | tm2622009d1_ex2-1.htm | https://www.sec.gov/Archives/edgar/data/1356576/000110465926089425/tm2622009d1_ex2-1.htm |
0001193125-26-330810 | 2130606 | Obsidian Therapeutics, Inc. | OBX | 2026-08-03 | 8-K | topline | false | d309963dex991.htm | https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex991.htm |
0001193125-26-330810 | 2130606 | Obsidian Therapeutics, Inc. | OBX | 2026-08-03 | 8-K | crl | true | d309963dex993.htm | https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex993.htm |
0001193125-26-330810 | 2130606 | Obsidian Therapeutics, Inc. | OBX | 2026-08-03 | 8-K | clinical_hold | true | d309963dex993.htm | https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex993.htm |
0001193125-26-330810 | 2130606 | Obsidian Therapeutics, Inc. | OBX | 2026-08-03 | 8-K | breakthrough | false | d309963dex993.htm | https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex993.htm |
0001193125-26-330810 | 2130606 | Obsidian Therapeutics, Inc. | OBX | 2026-08-03 | 8-K | fast_track | false | d309963dex993.htm | https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex993.htm |
0001193125-26-330810 | 2130606 | Obsidian Therapeutics, Inc. | OBX | 2026-08-03 | 8-K | orphan | false | d309963dex993.htm | https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex993.htm |
0001193125-26-330810 | 2130606 | Obsidian Therapeutics, Inc. | OBX | 2026-08-03 | 8-K | pdufa | false | d309963dex993.htm | https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex993.htm |
0001193125-26-330810 | 2130606 | Obsidian Therapeutics, Inc. | OBX | 2026-08-03 | 8-K | ind | false | d309963dex1013.htm | https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/d309963dex1013.htm |
0001104659-26-089443 | 1393434 | OCULAR THERAPEUTIX, INC | OCUL | 2026-08-03 | 8-K | topline | false | tm2621618d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1393434/000110465926089443/tm2621618d1_ex99-1.htm |
0001140361-26-030985 | 1506492 | Nuwellis, Inc. | NUWE | 2026-08-03 | 8-K | clinical_hold | true | ef20079229_ex10-2.htm | https://www.sec.gov/Archives/edgar/data/1506492/000114036126030985/ef20079229_ex10-2.htm |
0001437749-26-025474 | 1659617 | Moleculin Biotech, Inc. | MBRX | 2026-08-03 | 8-K | clinical_hold | true | ex_997517.htm | https://www.sec.gov/Archives/edgar/data/1659617/000143774926025474/ex_997517.htm |
0001711279-26-000058 | 1711279 | Krystal Biotech, Inc. | KRYS | 2026-08-03 | 8-K | topline | false | a2q26-ex991xpressrelease.htm | https://www.sec.gov/Archives/edgar/data/1711279/000171127926000058/a2q26-ex991xpressrelease.htm |
0001232524-26-000044 | 1232524 | Jazz Pharmaceuticals plc | JAZZ | 2026-08-03 | 8-K | topline | false | a2q26financialpr.htm | https://www.sec.gov/Archives/edgar/data/1232524/000123252426000044/a2q26financialpr.htm |
0001232524-26-000044 | 1232524 | Jazz Pharmaceuticals plc | JAZZ | 2026-08-03 | 8-K | interim | false | a2q26financialpr.htm | https://www.sec.gov/Archives/edgar/data/1232524/000123252426000044/a2q26financialpr.htm |
0001232524-26-000044 | 1232524 | Jazz Pharmaceuticals plc | JAZZ | 2026-08-03 | 8-K | breakthrough | false | a2q26financialpr.htm | https://www.sec.gov/Archives/edgar/data/1232524/000123252426000044/a2q26financialpr.htm |
0001232524-26-000044 | 1232524 | Jazz Pharmaceuticals plc | JAZZ | 2026-08-03 | 8-K | pdufa | false | a2q26financialpr.htm | https://www.sec.gov/Archives/edgar/data/1232524/000123252426000044/a2q26financialpr.htm |
0001193125-26-329513 | 1625297 | Indivior Pharmaceuticals, Inc. | INDV | 2026-08-03 | 8-K | clinical_hold | true | d28447dex21.htm | https://www.sec.gov/Archives/edgar/data/1625297/000119312526329513/d28447dex21.htm |
0001493152-26-035743 | 1412486 | Cocrystal Pharma, Inc. | COCP | 2026-08-03 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1412486/000149315226035743/ex99-1.htm |
0001193125-26-330644 | 1674416 | CRISPR Therapeutics AG | CRSP | 2026-08-03 | 8-K | ind | false | crsp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1674416/000119312526330644/crsp-ex99_1.htm |
0001731122-26-001000 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-08-03 | 8-K | orphan | false | e7823_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001000/e7823_ex99-1.htm |
0001339970-26-000042 | 1339970 | aTYR PHARMA INC | ATYR | 2026-07-31 | 8-K | orphan | false | atyr-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1339970/000133997026000042/atyr-ex99_1.htm |
0001193125-26-326784 | 34956 | TENAX THERAPEUTICS, INC. | TENX | 2026-07-31 | 8-K | topline | false | d90330dex991.htm | https://www.sec.gov/Archives/edgar/data/34956/000119312526326784/d90330dex991.htm |
0001062993-26-003959 | 1591956 | Sphere 3D Corp. | ANY | 2026-07-31 | 8-K | clinical_hold | true | exhibit10-1.htm | https://www.sec.gov/Archives/edgar/data/1591956/000106299326003959/exhibit10-1.htm |
0001062993-26-003959 | 1591956 | Sphere 3D Corp. | ANY | 2026-07-31 | 8-K | ind | false | exhibit10-1.htm | https://www.sec.gov/Archives/edgar/data/1591956/000106299326003959/exhibit10-1.htm |
0001437749-26-025167 | 1659617 | Moleculin Biotech, Inc. | MBRX | 2026-07-31 | 8-K | interim | false | ex_995334.htm | https://www.sec.gov/Archives/edgar/data/1659617/000143774926025167/ex_995334.htm |
0001437749-26-025167 | 1659617 | Moleculin Biotech, Inc. | MBRX | 2026-07-31 | 8-K | orphan | false | ex_995334.htm | https://www.sec.gov/Archives/edgar/data/1659617/000143774926025167/ex_995334.htm |
0001682852-26-000147 | 1682852 | Moderna, Inc. | MRNA | 2026-07-31 | 8-K | interim | false | exhibit9912026q2pressrelea.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285226000147/exhibit9912026q2pressrelea.htm |
0001682852-26-000147 | 1682852 | Moderna, Inc. | MRNA | 2026-07-31 | 8-K | pdufa | false | exhibit9912026q2pressrelea.htm | https://www.sec.gov/Archives/edgar/data/1682852/000168285226000147/exhibit9912026q2pressrelea.htm |
0001193125-26-326995 | 1503802 | Karyopharm Therapeutics Inc. | KPTI | 2026-07-31 | 8-K | topline | false | d71318d8k.htm | https://www.sec.gov/Archives/edgar/data/1503802/000119312526326995/d71318d8k.htm |
0001193125-26-326995 | 1503802 | Karyopharm Therapeutics Inc. | KPTI | 2026-07-31 | 8-K | endpoint_missed | true | d71318d8k.htm | https://www.sec.gov/Archives/edgar/data/1503802/000119312526326995/d71318d8k.htm |
0001213900-26-083961 | 1711754 | Inmune Bio, Inc. | INMB | 2026-07-31 | 8-K | fast_track | false | ea030006901ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1711754/000121390026083961/ea030006901ex99-1.htm |
0001193125-26-326785 | 1055726 | INOVIO PHARMACEUTICALS, INC. | INO | 2026-07-31 | 8-K | ind | false | d253972dex11.htm | https://www.sec.gov/Archives/edgar/data/1055726/000119312526326785/d253972dex11.htm |
0001493152-26-035550 | 1641631 | Beyond Air, Inc. | XAIR | 2026-07-31 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1641631/000149315226035550/ex10-1.htm |
0001551152-26-000023 | 1551152 | AbbVie Inc. | ABBV | 2026-07-31 | 8-K | topline | false | abbv-20260630xexhibit991.htm | https://www.sec.gov/Archives/edgar/data/1551152/000155115226000023/abbv-20260630xexhibit991.htm |
0001551152-26-000023 | 1551152 | AbbVie Inc. | ABBV | 2026-07-31 | 8-K | endpoint_met | false | abbv-20260630xexhibit991.htm | https://www.sec.gov/Archives/edgar/data/1551152/000155115226000023/abbv-20260630xexhibit991.htm |
0001193125-26-324917 | 1631574 | Wave Life Sciences Ltd. | WVE | 2026-07-30 | 8-K | topline | false | d177737dex992.htm | https://www.sec.gov/Archives/edgar/data/1631574/000119312526324917/d177737dex992.htm |
0001104659-26-088461 | 1346830 | Tvardi Therapeutics, Inc. | TVRD | 2026-07-30 | 8-K | topline | false | tm2621651d1_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1346830/000110465926088461/tm2621651d1_ex99-2.htm |
0001104659-26-088461 | 1346830 | Tvardi Therapeutics, Inc. | TVRD | 2026-07-30 | 8-K | ind | false | tm2621651d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1346830/000110465926088461/tm2621651d1_ex99-1.htm |
0001104659-26-088481 | 1737953 | Replimune Group, Inc. | REPL | 2026-07-30 | 8-K | breakthrough | false | tm2621663d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1737953/000110465926088481/tm2621663d1_ex99-1.htm |
0001193125-26-324786 | 1662774 | Quince Therapeutics, Inc. | QNCX | 2026-07-30 | 8-K | topline | false | d163930dex998.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526324786/d163930dex998.htm |
0001193125-26-324786 | 1662774 | Quince Therapeutics, Inc. | QNCX | 2026-07-30 | 8-K | crl | true | d163930dex994.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526324786/d163930dex994.htm |
0001193125-26-324786 | 1662774 | Quince Therapeutics, Inc. | QNCX | 2026-07-30 | 8-K | clinical_hold | true | d163930dex994.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526324786/d163930dex994.htm |
0001193125-26-324786 | 1662774 | Quince Therapeutics, Inc. | QNCX | 2026-07-30 | 8-K | breakthrough | false | d163930dex994.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526324786/d163930dex994.htm |
0001193125-26-324786 | 1662774 | Quince Therapeutics, Inc. | QNCX | 2026-07-30 | 8-K | fast_track | false | d163930dex994.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526324786/d163930dex994.htm |
0001193125-26-324786 | 1662774 | Quince Therapeutics, Inc. | QNCX | 2026-07-30 | 8-K | orphan | false | d163930dex994.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526324786/d163930dex994.htm |
0001193125-26-324786 | 1662774 | Quince Therapeutics, Inc. | QNCX | 2026-07-30 | 8-K | pdufa | false | d163930dex994.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526324786/d163930dex994.htm |
0001193125-26-324865 | 1783183 | Phathom Pharmaceuticals, Inc. | PHAT | 2026-07-30 | 8-K | topline | false | d114879dex991.htm | https://www.sec.gov/Archives/edgar/data/1783183/000119312526324865/d114879dex991.htm |
0001104659-26-088393 | 1379006 | NANOVIRICIDES, INC. | NNVC | 2026-07-30 | 8-K | orphan | false | tm2621493d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1379006/000110465926088393/tm2621493d1_ex99-1.htm |
0001628280-26-050775 | 1157601 | MADRIGAL PHARMACEUTICALS, INC. | MDGL | 2026-07-30 | 8-K | topline | false | exhibit991-63026earningspr.htm | https://www.sec.gov/Archives/edgar/data/1157601/000162828026050775/exhibit991-63026earningspr.htm |
0001193125-26-324866 | 1314102 | EyePoint, Inc. | EYPT | 2026-07-30 | 8-K | topline | false | eypt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1314102/000119312526324866/eypt-ex99_1.htm |
0001193125-26-324972 | 2044725 | Evommune, Inc. | EVMN | 2026-07-30 | 8-K | topline | false | evmn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2044725/000119312526324972/evmn-ex99_1.htm |
0001193125-26-325031 | 1816736 | Disc Medicine, Inc. | IRON | 2026-07-30 | 8-K | topline | false | iron-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1816736/000119312526325031/iron-ex99_1.htm |
0001193125-26-325031 | 1816736 | Disc Medicine, Inc. | IRON | 2026-07-30 | 8-K | orphan | false | iron-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1816736/000119312526325031/iron-ex99_1.htm |
0001628280-26-051051 | 1855175 | Contineum Therapeutics, Inc. | CTNM | 2026-07-30 | 8-K | topline | false | q220268kex991.htm | https://www.sec.gov/Archives/edgar/data/1855175/000162828026051051/q220268kex991.htm |
0001104659-26-088667 | 1133869 | CAPRICOR THERAPEUTICS, INC. | CAPR | 2026-07-30 | 8-K | orphan | false | capr-20260729xex99.htm | https://www.sec.gov/Archives/edgar/data/1133869/000110465926088667/capr-20260729xex99.htm |
0001104659-26-088667 | 1133869 | CAPRICOR THERAPEUTICS, INC. | CAPR | 2026-07-30 | 8-K | pdufa | false | capr-20260729x8k.htm | https://www.sec.gov/Archives/edgar/data/1133869/000110465926088667/capr-20260729x8k.htm |
0000014272-26-000018 | 14272 | BRISTOL MYERS SQUIBB CO | null | 2026-07-30 | 8-K | pdufa | false | q22026earningspresentati.htm | https://www.sec.gov/Archives/edgar/data/14272/000001427226000018/q22026earningspresentati.htm |
0001104659-26-088728 | 1137883 | BRAINSTORM CELL THERAPEUTICS INC. | BCLI | 2026-07-30 | 8-K | orphan | false | tm2621592d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1137883/000110465926088728/tm2621592d1_ex99-1.htm |
0001104659-26-088455 | 1761612 | BICYCLE THERAPEUTICS PLC | BCYC | 2026-07-30 | 8-K | interim | false | tm2621593d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1761612/000110465926088455/tm2621593d1_ex99-1.htm |
0001193125-26-326199 | 1528115 | Annexon, Inc. | ANNX | 2026-07-30 | 8-K | crl | true | d113783dex101.htm | https://www.sec.gov/Archives/edgar/data/1528115/000119312526326199/d113783dex101.htm |
0001723128-26-000025 | 1723128 | Amneal Pharmaceuticals, Inc. | AMRX | 2026-07-30 | 8-K | crl | true | amrx-q22026ex991.htm | https://www.sec.gov/Archives/edgar/data/1723128/000172312826000025/amrx-q22026ex991.htm |
0001731122-26-000988 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-07-30 | 8-K | fast_track | false | e7813_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226000988/e7813_ex99-1.htm |
0001731122-26-000988 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-07-30 | 8-K | orphan | false | e7813_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226000988/e7813_ex99-1.htm |
0001439222-26-000115 | 1439222 | AGIOS PHARMACEUTICALS, INC. | AGIO | 2026-07-30 | 8-K | pdufa | false | agio-73026xfyxex991earning.htm | https://www.sec.gov/Archives/edgar/data/1439222/000143922226000115/agio-73026xfyxex991earning.htm |
0001104659-26-087808 | 1590560 | uniQure N.V. | QURE | 2026-07-29 | 8-K | topline | false | qure-20260729xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1590560/000110465926087808/qure-20260729xex99d1.htm |
0001193125-26-323652 | 1607678 | Viking Therapeutics, Inc. | VKTX | 2026-07-29 | 8-K | topline | false | vktx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1607678/000119312526323652/vktx-ex99_1.htm |
0001193125-26-322160 | 1527599 | SYNLOGIC, INC. | SYBX | 2026-07-29 | 8-K | clinical_hold | true | d91010dex104.htm | https://www.sec.gov/Archives/edgar/data/1527599/000119312526322160/d91010dex104.htm |
0001493152-26-035099 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-07-29 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1533743/000149315226035099/ex99-1.htm |
0001493152-26-035099 | 1533743 | Processa Pharmaceuticals, Inc. | PCSA | 2026-07-29 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1533743/000149315226035099/ex10-1.htm |
0001213900-26-082879 | 1782107 | Onconetix, Inc. | ONCO | 2026-07-29 | 8-K | clinical_hold | true | ea029951001ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1782107/000121390026082879/ea029951001ex10-1.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.